JP2013539765A5 - - Google Patents

Download PDF

Info

Publication number
JP2013539765A5
JP2013539765A5 JP2013532985A JP2013532985A JP2013539765A5 JP 2013539765 A5 JP2013539765 A5 JP 2013539765A5 JP 2013532985 A JP2013532985 A JP 2013532985A JP 2013532985 A JP2013532985 A JP 2013532985A JP 2013539765 A5 JP2013539765 A5 JP 2013539765A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
heterocyclyl
heteroaryl
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013532985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013539765A (ja
JP6023062B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/055428 external-priority patent/WO2012048259A2/en
Publication of JP2013539765A publication Critical patent/JP2013539765A/ja
Publication of JP2013539765A5 publication Critical patent/JP2013539765A5/ja
Application granted granted Critical
Publication of JP6023062B2 publication Critical patent/JP6023062B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013532985A 2010-10-08 2011-10-07 置換ピリダジンカルボキサミド化合物 Active JP6023062B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39142310P 2010-10-08 2010-10-08
US61/391,423 2010-10-08
PCT/US2011/055428 WO2012048259A2 (en) 2010-10-08 2011-10-07 Substituted pyridazine carboxamide compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016124463A Division JP6235078B2 (ja) 2010-10-08 2016-06-23 置換ピリダジンカルボキサミド化合物

Publications (3)

Publication Number Publication Date
JP2013539765A JP2013539765A (ja) 2013-10-28
JP2013539765A5 true JP2013539765A5 (https=) 2016-09-01
JP6023062B2 JP6023062B2 (ja) 2016-11-09

Family

ID=45928473

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013532985A Active JP6023062B2 (ja) 2010-10-08 2011-10-07 置換ピリダジンカルボキサミド化合物
JP2016124463A Active JP6235078B2 (ja) 2010-10-08 2016-06-23 置換ピリダジンカルボキサミド化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016124463A Active JP6235078B2 (ja) 2010-10-08 2016-06-23 置換ピリダジンカルボキサミド化合物

Country Status (12)

Country Link
US (3) US9126947B2 (https=)
EP (1) EP2625176B1 (https=)
JP (2) JP6023062B2 (https=)
KR (1) KR101886812B1 (https=)
CN (1) CN103298806B (https=)
AU (1) AU2011311814B2 (https=)
BR (1) BR112013008523B1 (https=)
CA (1) CA2813607C (https=)
EA (1) EA024809B1 (https=)
ES (1) ES2610226T3 (https=)
PL (1) PL2625176T3 (https=)
WO (1) WO2012048259A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2550264B1 (en) * 2010-03-23 2016-06-08 Basf Se Pyridazine compounds for controlling invertebrate pests
EA024809B1 (ru) * 2010-10-08 2016-10-31 Икскавери Холдинг Кампани, Ллс Замещенные соединения пиридазинкарбоксамида
JP6013029B2 (ja) * 2012-05-25 2016-10-25 千葉県 抗癌剤
RU2550346C2 (ru) * 2013-09-26 2015-05-10 Общество с ограниченной ответственностью "Отечественные Фармацевтические Технологии" ООО"ФармТех" Новые химические соединения (варианты) и их применение для лечения онкологических заболеваний
CN105085550B (zh) * 2014-05-21 2017-05-24 海门慧聚药业有限公司 一类alk激酶抑制剂及其制备方法
RU2015110071A (ru) * 2015-03-23 2016-10-10 Общество с ограниченной ответственностью "Отечественные Фармацевтические Технологии" ООО "ФармТех" Применение новых химических соединений (варианты) в качестве ингибиторов nuak1 киназы для лечения онкологических заболеваний
TWI646094B (zh) 2016-06-01 2019-01-01 大陸商貝達藥業股份有限公司 Crystal form of inhibitory protein kinase active compound and application thereof
RU2631430C1 (ru) * 2016-10-26 2017-09-22 Общество С Ограниченной Ответственностью "Отечественные Фармацевтические Технологии" НОВЫЙ СПОСОБ СИНТЕЗА ПРОИЗВОДНЫХ ТЕТРАГИДРОПИРАЗИНО[2,3-c]ПИРИДАЗИНА
CN110357889B (zh) * 2018-04-09 2022-03-15 上海科技大学 蛋白降解靶向化合物、其抗肿瘤应用、其中间体及中间体应用
EP3932922A4 (en) 2019-02-25 2022-05-11 ShanghaiTech University SULPHUR-CONTAINING COMPOUND BASED ON A GLUTARIMIDE FRAMEWORK AND ITS USE
WO2021023233A1 (zh) 2019-08-05 2021-02-11 上海科技大学 Egfr蛋白降解剂及其抗肿瘤应用
EP4188922A1 (en) 2020-08-03 2023-06-07 Teva Pharmaceuticals International GmbH Solid state forms of ensartinib and ensartinib salts
EP4385510A4 (en) * 2021-08-10 2025-08-20 Betta Pharmaceuticals Co Ltd USE OF ENSARTINIB OR A CORRESPONDING SALT IN THE TREATMENT OF A DISEASE CARRYING A MET EXON 14 SKIPPING MUTATION
CN116082110B (zh) * 2023-01-09 2024-04-12 北京肿瘤医院(北京大学肿瘤医院) 一种11c标记靶向间变性淋巴瘤激酶alk突变分子探针及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3583799D1 (de) 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
JP2773959B2 (ja) 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
DE69924735T2 (de) 1998-07-28 2006-01-19 Tanabe Seiyaku Co., Ltd. Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US6800663B2 (en) 2002-10-18 2004-10-05 Alkermes Controlled Therapeutics Inc. Ii, Crosslinked hydrogel copolymers
CA2517256C (en) 2003-02-26 2013-04-30 Sugen, Inc. Aminoheteroaryl compounds as protein kinase inhibitors
BRPI0514687A (pt) * 2004-08-26 2008-06-17 Pfizer compostos amino heteroarila como inibidores de proteìna tirosina cinase
ME01309B (me) 2004-08-26 2013-12-20 Pfizer Pirazolom supstituirani heteroarilni spojevi kao inhibitori proteinskih kinaza
WO2008088881A1 (en) 2007-01-19 2008-07-24 Xcovery, Inc. Kinase inhibitor compounds
ES2670665T3 (es) * 2008-06-19 2018-05-31 Xcovery Holding Company Llc Compuestos de piridazina carboxamida sustituidos como compuestos inhibidores de quinasa
EA024809B1 (ru) * 2010-10-08 2016-10-31 Икскавери Холдинг Кампани, Ллс Замещенные соединения пиридазинкарбоксамида
WO2012048258A2 (en) * 2010-10-08 2012-04-12 Xcovery Holding Company, Llc Substituted pyridazine carboxamide compounds as kinase inhibitor compounds

Similar Documents

Publication Publication Date Title
JP2013539765A5 (https=)
CN107771178B (zh) 杂环化合物的合成
JP5873554B2 (ja) キラルジペプチジルペプチダーゼ−iv阻害剤の調製プロセス
ES2587903T3 (es) Compuestos de imidazolidinadiona y sus usos
KR101934096B1 (ko) 이델라리십의 제조방법
WO2016106384A1 (en) Processes for preparing ask1 inhibitors
JP6567505B2 (ja) キナゾリン誘導体およびdnaメチルトランスフェラーゼ阻害剤としてのその使用
JP2013522327A (ja) ラパチニブの調製プロセス及び中間体
UA125317C2 (uk) Удосконалений спосіб отримання похідних амінопіримідину
JP6901976B2 (ja) キサンチンをベースとする化合物の調製方法
JP2023523854A (ja) Iapアンタゴニスト化合物及びその中間体、並びにそれを合成する方法
CN112585126B (zh) 四环化合物的制备方法
KR102477924B1 (ko) 인돌 카르복스아미드 화합물을 제조하는 방법
TW201722959A (zh) 依魯替尼之製備方法及其中間體
AU2020205355B2 (en) Chemical process for preparing imidazopyrrolidinone derivatives and intermediates thereof
CN102924454A (zh) 恩替卡韦的合成方法
WO2016071382A1 (en) Synthesis of pi3k inhibitor and salts thereof
JP5420549B2 (ja) エピポドフィロトキシンの(ポリ)アミノアルキルアミノアセトアミドの抗腫瘍性誘導体の合成方法
Cho et al. Synthesis and Substitution Reactions of 4 (6)-Chloro-dihydropyrimidines
JP2005112804A (ja) インドリルメチルアミノピロリジン誘導体およびその製造法
JP2012521993A (ja) 縮合三環式スルホンアミドの製造プロセス
HK40037319A (en) Process for making tricyclic lactam compounds
HK40006951B (en) Chemical process for preparing imidazopyrrolidinone derivatives and intermediates thereof
WO2016071380A1 (en) Synthesis of pi3k inhibitor and salts thereof